Efficacy of anakinra for various types of crystal-induced arthritis in complex hospitalized patients: A case series and review of the literature

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Aouba, A ^a,b   Deshayes, S ^a   Frenzel, L ^b   Decottignies, A ^c   Pressiat, C ^c   Bienvenu, B ^a   Boue, F ^a   Damaj, G ^a   Hermine, O ^b   Georgin Lavialle, S ^d  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

^d HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CALCIUM PYROPHOSPHATE; COLCHICINE; CREATININE; FEBUXOSTAT; HYDROXYUREA; INDOMETACIN; KETOPROFEN; PENTOSTATIN; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; GLUCOCORTICOID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTHRITIS; CASE STUDY; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROWNED DENS SYNDROME; CRYSTAL INDUCED ARTHRITIS; DIABETES MELLITUS; DIARRHEA; DISEASE CONTROL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FEVER; FOLLOW UP; GOUT; HEMATOLOGIC MALIGNANCY; HOSPITAL PATIENT; HUMAN; HYDROXYAPATITE DEPOSITION DISEASE; HYPERTENSION; HYPOTHYROIDISM; INFECTION; INJECTION SITE REACTION; MALE; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OUTCOME ASSESSMENT; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; PRURITUS; PSEUDOGOUT; RELAPSE; REMISSION; RETROSPECTIVE STUDY; REVIEW; SIDE EFFECT; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION; TREATMENT RESPONSE; VERY ELDERLY; ARTHRITIS, GOUTY; CASE REPORT; HOSPITALIZATION; INFLAMMATION; METABOLISM; TREATMENT OUTCOME;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS; ARTHRITIS, GOUTY; C-REACTIVE PROTEIN; COLCHICINE; COMORBIDITY; FEMALE; GLUCOCORTICOIDS; HOSPITALIZATION; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84927144516     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/792173     Document Type: Review

References (18)

1. A. So, T. de Smedt, S. Revaz, and J. Tschopp, "Apilot study of IL- 1 inhibition by anakinra in acute gout, " Arthritis Research and Therapy, vol. 9, no. 2, articleR28, 2007.
2. B. N. Cronstein and R. Terkeltaub, "The inflammatory process of gout and its treatment, " Arthritis Research & Therapy, vol. 8, supplement 1, articleS3, 2006.
3. F. Martinon, V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp, "Gout-associated uric acid crystals activate the NALP3 inflammasome, " Nature, vol. 440, no. 7081, pp. 237-241, 2006.
4. P. Ghosh, M. Cho, G. Rawat, P. A. Simkin, and G. C. Gardner, "Treatment of acute gouty arthritis in complex hospitalized patients with anakinra, " Arthritis Care and Research, vol. 65, no. 8, pp. 1381-1384, 2013.
5. D. McGonagle, A. L. Tan, J. Madden, P. Emery, and M. F. McDermott, "Successful treatment of resistant pseudogout with anakinra, " Arthritis and Rheumatism, vol. 58, no. 2, pp. 631-633, 2008.
6. A. Moltó, H.-K. Ea, P. Richette, T. Bardin, and F. Lioté, "Efficacy of anakinra for refractory acute calcium pyrophosphate crystal arthritis, " Joint Bone Spine, vol. 79, no. 6, pp. 621-623, 2012.
7. M. Couderc, S.Mathieu, B. Glace, and M. Soubrier, "Efficacy of anakinra in articular chondrocalcinosis: report of three cases, " Joint Bone Spine, vol. 79, no. 3, pp. 330-331, 2012.
8. S.-L. Wallace, H. Robinson, A. T. Masi, J. L. Decker, D. J. McCarty, and T. F. Yü, "Preliminary criteria for the classification of the acute arthritis of primary gout, " Arthritis & Rheumatism, vol. 20, no. 3, pp. 895-900, 1977.
9. L. Cantarini, G. Lopalco, F. Caso et al., "Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease, " Autoimmunity Reviews, vol. 14, no. 1, pp. 1-9, 2015.
10. C. Selmi, A. Ceribelli, S.M.Naguwa, L. Cantarini, and Y. Shoenfeld, "Safety issues and concerns of new immunomodulators in rheumatology, " Expert Opinion on Drug Safety, vol. 14, no. 3, pp. 389-399, 2015.
11. N. Announ, G. Palmer, P. A. Guerne, and C. Gabay, "Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure, " Joint Bone Spine, vol. 76, no. 4, pp. 424-426, 2009.
12. F. Verhoeven, C. Prati, M. Godfrin-Valnet, X. Guillot, and D. Wendling, "IL1 blockade in crystal-induced arthritis: impact of disease duration and the inflammatory syndrome. Comments on the article by Couderc M. et al. 'Efficacy of anakinra in articular chondrocalcinosis.', " Joint, Bone, Spine: Revue du Rhumatisme, vol. 80, no. 1, pp. 115-116, 2013.
13. B. Pazár, H. K. Ea, S. Narayan et al., "Basic calcium phosphate crystals induce monocyte/macrophage IL-1β secretion through theNLRP3 inflammasome in vitro, " Journal of Immunology, vol. 186, no. 4, pp. 2495-2502, 2011.
14. Z. H. Meng, A. P. Hudson, H. R. Schumacher Jr., J. F. Baker, and D. G. Baker, "Monosodium urate, hydroxyapatite, and calcium pyrophosphate crystals induce tumor necrosis factor-α expression in a mononuclear cell line, " The Journal of Rheumatology, vol. 24, no. 12, pp. 2385-2388, 1997.
15. G. Lopalco, L. Cantarini, A. Vitale et al., "Interleukin-1 as a common denominator from auto inflammatory to autoimmune disorders: premises, perils, and perspectives, " Mediators of Inflammation, vol. 2015, Article ID 194864, 21 pages, 2015.
16. A. G. Fam and J. Rubenstein, "Hydroxyapatite pseudopodagra. A syndrome of young women, " Arthritis and Rheumatism, vol. 32, no. 6, pp. 741-747, 1989.
17. L. Cantarini, O. M. Lucherini, B. Frediani et al., "Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes, " International Journal of Immuno pathology and Pharmacology, vol. 24, no. 4, pp. 827-836, 2011.
18. D. Rigante, G. Lopalco, A. Vitale et al., "Untangling the web of systemic auto inflammatory diseases, " Mediators of Inflammation, vol. 2014, ArticleID948154, 15 pages, 2014.